Hamad Medical Corporation (HMC) recently held its First Qatar Gynecological Malignancy Symposium addressing current and important issues in gynecological oncology, focused on the development of collaborative research and training in the GCC and the MENA region.

The symposium brought together renowned local, regional and international experts in the field of gynecological oncology, and included an address during the opening ceremony from Professor Alexander Knuth, CEO and Medical Director of the National Centre for Cancer Care and Research (NCCCR) and Chairman of Cancer Services at HMC. He provided an overview of cancer transformation in Qatar and of its achievements .

The symposium covered key topics such as preserving fertility in cervical cancer patients, managing gynecological cancer during pregnancy, endometrial cancer, and epidemiology. Dr Salha Bujassoum, Senior Consultant in Hematology/Oncology at NCCCR said the symposium consolidated HMC’s commitment to providing the safest, most effective and most compassionate care to patients. She said she believes that the symposium is the first step to creating a community of specialists and leaders in gynecological oncology in the region.

Dr Hind El Malik, Medical Oncology Consultant at HMC and Chair of the scientific planning and organising committees was delighted with the success of the symposium and acknowledged the support of various health and medical companies for sponsoring the event.

Check hamad.qa for more information about the symposium.